| Jackie Elbonne |
Jackie Elbonne currently works at Amgen, Inc., as Chief Quality Officer & Senior Vice President from 2022. Ms. Elbonne also formerly worked at Bristol Myers Squibb Co., as Chief Quality Officer. Ms. Elbonne received her undergraduate degree and doctorate degree from The University of Liverpool. |
| Howard Y. Chang |
Howard Y. Chang is the founder of Accent Therapeutics, Inc. (2017). Dr. Chang is also the founder of Epinomics, Inc., Cartography Biosciences, Inc., Orbital Therapeutics, Inc. Dr. Chang is currently the Chief Scientific Officer & SVP-Global Research at Amgen, Inc. since 2024, and a member of the National Academy of Sciences, American Academy of Arts & Sciences, and National Academy of Medicine (United States). Education includes an undergraduate degree from Harvard University, a doctorate from the Massachusetts Institute of Technology, and a doctorate from Harvard Medical School. |
| Esteban Santos |
Esteban Santos currently works at Amgen, Inc., as Executive Vice President-Operations from 2016. Mr. Santos also formerly worked at Johnson & Johnson, as General Manager-Cordis Site from 2004 to 2007. Mr. Santos received his graduate degree from Rensselaer Polytechnic Institute and undergraduate degree from the University of Puerto Rico. |
| Jean-Charles Soria |
Jean-Charles Soria is the founder of Gritstone bio, Inc. (2015). Current jobs include Director-General at Institut Gustave Roussy EURL (since 2017), Professor at Université Paris-Saclay, and Senior VP-Research & Development at Amgen, Inc. (since 2021). Former jobs include Independent Director at HOOKIPA Pharma, Inc., Senior Vice President at MedImmune LLC (2017-2019), Senior Vice President at AstraZeneca PLC (2017-2019), Member-Supervisory Board at Innate Pharma SA (2017), Associate Professor at The University of Texas M.D. Anderson Cancer Center (2013-2017), and Senior VP-Oncology Research & Development at AstraZeneca US (2017-2019). |
| David M. Reese |
David M. Reese was the founder of Translational Oncology Research International, Inc. (2003) and served as President & Chief Medical Officer. Current jobs include Chief Executive Officer at Onyx Pharmaceuticals, Inc., Chief Executive Officer at KAI Pharmaceuticals, Inc., Chief Executive Officer at Five Prime Therapeutics, Inc., Chief Executive Officer at ChemoCentryx, Inc., President & Director at Alantos Pharmaceuticals Holding, Inc., President & Director at BioVex Group, Inc., Director at CEO Roundtable on Cancer, Inc., Director at Research!America (2023), and Chief Technology Officer & Executive VP at Amgen, Inc. Former jobs include Director-Clinical Research at Translational Research In Oncology and Director-Clinical Research at Breast Cancer International Research Group Ltd. Education includes undergraduate degrees from The University of Cincinnati College of Medicine and Harvard College. |
| Darryl Sleep |
Darryl Sleep currently works at Amgen, Inc., as Senior Vice President-Global Medical. Dr. Sleep also formerly worked at the University of Pretoria, as Professor, Takeda Pharmaceuticals U.S.A., Inc., as Senior VP, Head-US Medical Office & Affairs from 2016 to 2018, Johannesburg Academic Hospital, as Head-Urology, and Kalafong Academic Hospital, as Academic Head-Urology Department. Dr. Sleep received his undergraduate degree in 1983 from the University of the Witwatersrand. |
| Sam Guhan |
Sam Guhan currently works at Amgen, Inc., as Senior Vice President-Global Engineering from 2024. Dr. Guhan received his graduate degree from Yale University and doctorate degree from Rensselaer Polytechnic Institute. |
| Yang Li |
Yang Li currently works at Amgen, Inc., as Scientific Director and Surrozen, Inc., as Executive Vice President-Research from 2023. Dr. Li received his doctorate degree from Stanford University and undergraduate degree from The Pennsylvania State University. |
| Matthew C. Busch |
Matthew C. Busch currently works at Amgen, Inc., as Chief Accounting Officer & Vice President-Finance from 2023. Mr. Busch received his undergraduate degree and graduate degree from Brigham Young University. |
| Linda H. Louie |
Linda H. Louie is currently working as the Vice President-Finance at Amgen, Inc. She started this position in 2020 and is currently employed there. Ms. Louie holds an MBA from The Fuqua School of Business. |
| Peter H. Griffith |
Peter H. Griffith currently works at Amgen, Inc., as Chief Financial Officer & Executive Vice President from 2020. Mr. Griffith also formerly worked at Ernst & Young Global Ltd., as Global Vice Chairman-Corporate Development from 2014 to 2019, Wedbush Securities, Inc., as Managing Director & Head-Investment Banking from 1989 to 1997, and Sherwood Canyon Group LLC, as President in 2019. Mr. Griffith received his undergraduate degree from USC Marshall School of Business. |
| Scott Skellenger |
Scott Skellenger currently works at Amgen, Inc., as Chief Information Officer & Senior VP from 2024. Mr. Skellenger also formerly worked at Amgen, Inc., as Principal, Illumina, Inc., as Principal, and RT Oncology Services Corp., as Chief Information Officer & Vice President. Mr. Skellenger received his undergraduate degree and Masters Business Admin degree from California Lutheran University. |
| Robert A. Bradway |
Robert A. Bradway currently works at Amgen, Inc., as Chairman, President & Chief Executive Officer, CEO Roundtable on Cancer, Inc., as Chairman, The Boeing Co., as Independent Director from 2016, W.M. Keck Foundation, Inc., as Director, Amgen Rockville, Inc., as Director from 2012, Pharmaceutical Research & Manufacturers of America, as Director from 2019, the University of Southern California, as Trustee from 2014, and American Heart Association, Inc., as Member. Mr. Bradway also formerly worked at Norfolk Southern Corp., as Independent Director from 2011 to 2017, Alantos Pharmaceuticals Holding, Inc., as Chief Financial Officer & Director, Morgan Stanley & Co. International Plc, as Managing Director, and Morgan Stanley & Co. LLC, as Principal from 1987 to 2005. Mr. Bradway received his undergraduate degree from Amherst College and Masters Business Admin degree from Harvard Business School. |
| Nancy A. Grygiel |
Nancy A. Grygiel currently works at Amgen Foundation, Inc., as Director, United Way of Ventura County, as Director, and Amgen, Inc., as Chief Compliance Officer from 2020. Ms. Grygiel also formerly worked at Allergan, Inc., as VP-Compliance, Corporate & International from 2011 to 2015. Ms. Grygiel received her graduate degree from Universidad de Buenos Aires and graduate degree from Georgetown University Law Center. |
| Derek Miller |
Derek Miller currently works at Amgen, Inc., as Chief Human Resources Officer from 2022 and Southeast Alabama Medical Center, as Chief Financial Officer & Senior Vice President from 2009. Mr. Miller received his Masters Business Admin degree from National University of Singapore, undergraduate degree from Grinnell College, and Masters Business Admin degree from Anderson School of Management. |
| James E. Bradner |
James E. Bradner is the founder of Tensha Therapeutics, Inc. (2011), Acetylon Pharmaceuticals, Inc. (2008), C4 Therapeutics, Inc. (2015), TetraLogic Research & Development Corp. (2008), and Syros Pharmaceuticals, Inc. (2011). Titles held included Director at Acetylon Pharmaceuticals, Inc. and TetraLogic Research & Development Corp., and Director at Syros Pharmaceuticals, Inc. from 2011 to 2015. Current jobs include Chairman at Novartis Institute for Functional Genomics, Inc., Director at Foundation for the National Institutes of Health, Inc. since 2023, Executive VP-Research & Development at Amgen, Inc. starting in 2024, Associate Professor at Harvard Medical School, and Advisor at Longwood Fund Management LLC. Former jobs include Associate Director-Therapeutics Science Centre at The Broad Institute, Inc., Member-Supervisory Board at QIAGEN NV in 2015, Member of the American Chemical Society, Member of the American Society of Hematology, and President at Novartis Institutes for Biomedical Research, Inc. from 2016 to 2022. Education includes an undergraduate degree from Harvard University conferred in 1994 and a doctorate from Pritzker School of Medicine. |
| Paul Burton |
Paul Burton currently works at Amgen, Inc., as Chief Medical Officer & Senior Vice President from 2023, Janssen Pharmaceuticals, Inc., as Chief Global Medical Affairs Officer from 2020, and Royal College of Surgeons, as Member. Dr. Burton also formerly worked at Johnson & Johnson, as Chief Global Medical Affairs Officer, Janssen Research & Development LLC, as Vice President, and Moderna, Inc., as Chief Medical Officer from 2021 to 2023. Dr. Burton received his doctorate degree from Imperial College London and doctorate degree from the University of London. |
| Ellen Jamison Kullman |
Ellen Jamison Kullman currently works at DuPont Argentina SRL, as Chief Executive Officer, Carbon, Inc., as Executive Chairman from 2022, Amgen, Inc., as Independent Director from 2016, and various other companies. Ms. Kullman also formerly worked at EIDP, Inc., as Chairman, President & Chief Executive Officer from 2009 to 2015, Axalta Coating Systems LLC, as Chairman & Chief Executive Officer, DuPont de Nemours, Inc., as Chairman & Chief Executive Officer from 2009 to 2015, and various other companies. Ms. Kullman received her undergraduate degree from Tufts University and graduate degree from Kellogg School of Management. |
| Amy E. Miles |
Ms. Amy E. Miles, CPA, is an Independent Director at Carrier Global Corp., an Independent Director at Amgen, Inc., an Independent Director at Gap, Inc. and a Chairman at Suntex Marinas LLC. She is on the Board of Directors at Carrier Global Corp., Amgen, Inc., Gap, Inc., Digital Cinema Implementation Partners LLC, Open Road Films LLC, Regal Foundation, Variety of Eastern Tennessee and Boys & Girls Clubs of The Tennessee Valley. Ms. Miles was previously employed as an Independent Director by Townsquare Media, Inc., an Independent Non-Executive Chairman by Norfolk Southern Corp., a President & Director by United Artists Theatre Circuit, Inc., a Chairman & Chief Executive Officer by Regal Entertainment Group, a Chief Executive Officer by Regal Cinemas, Inc., a Senior Manager by Deloitte & Touche LLP, a Senior Manager by PricewaterhouseCoopers LLP, and a Chairman by National Association of Theatre Owners. She also served on the board at ASM Global Parent, Inc., National CineMedia, Inc., National CineMedia LLC and PetSafe Brands. She received her undergraduate degree from the University of Tennessee. |
| Wanda M. Austin |
Wanda M. Austin is the founder of Making Space, Inc. since 2017, serving as Chief Executive Officer. Current jobs include Chairman at Hampton Roads Chapter of The American Red Cross since 2010, Independent Director at Amgen, Inc. since 2017, Lead Independent Director at Chevron Corp. since 2022, Director at Horatio Alger Association of Distinguished Americans, Inc., President at USC Norris Comprehensive Cancer Center since 2018, Member at National Academy of Engineering, Member at International Academy of Astronautics, and Independent Director at Apple, Inc. starting in 2024. Former jobs include President, Chief Executive Officer & Trustee at The Aerospace Corp. from 2008 to 2016, Director at The National Geographic Society, Inc., Director at The Charles Stark Draper Laboratory, Inc., Director at U.S. Space Foundation from 2013 to 2015, Independent Director at Virgin Galactic Holdings, Inc. from 2019 to 2023, President at the University of Southern California from 2018 to 2019, Member at National Aeronautics & Space Administration, Principal at The California Council on Science & Technology from 2008 to 2013, and Principal at United States Defense Science Board from 2010 to 2016. Education includes a graduate degree from the University of Pittsburgh, a doctorate from the University of Southern California conferred in 1988, and an undergraduate degree from Franklin & Marshall College. |
| Michael V. Drake |
Michael V. Drake currently works at Amgen, Inc., as Independent Director from 2022, Bank of the West (California), as Director from 2010, and the University of California, as President from 2020. Dr. Drake also formerly worked at Association of Academic Health Centers, as Chairman, BancWest Corp. (Hawaii), as Director, California HealthCare Foundation, as Director, Orange County Performing Art Center, as Director, The Ohio State University Wexner Medical Center, as President & Director from 2014 to 2020, and the University of California, Irvine, as Chancellor from 2005 to 2014. Dr. Drake received his undergraduate degree from Stanford University and doctorate degree from The University of California, San Francisco. |
| Tyler E. Jacks |
Tyler E. Jacks is the founder of T2 Biosystems, Inc. (2006) and Dragonfly Therapeutics, Inc. (2016). Current jobs include Independent Director at Amgen, Inc. (2012), Director at Thermo Fisher Scientific, Inc. (2009), President & Director at Commonwealth Cancer Consortium, Inc. (2021), and Professor at Massachusetts Institute of Technology (2007). Former jobs include Chairman at National Cancer Institute and Director at David H. Koch Institute for Integrative Cancer Research (2001-2021). Education includes an undergraduate degree from Harvard University (1983) and a doctorate from The University of California, San Francisco (1988). |
| Brian J. Druker |
Dr. Brian J. Druker, MD, is an Independent Director at Vincerx Pharma, Inc., an Independent Director at Amgen, Inc. and a Director & Associate Dean at Oregon Health & Science University. He is on the Board of Directors at Vincerx Pharma, Inc., Amgen, Inc., Oregon Health & Science University and The Burroughs Wellcome Fund. Dr. Druker was previously employed as a Co-Founder by Blueprint Medicines Corp., a Chief Executive Officer & Director by OHSU Knight Cancer Institute, and a Founder by MolecularMD Corp. He received his undergraduate degree from the University of California San Diego and a doctorate degree from the University of California San Diego. |
| Omar Syed Ishrak |
Omar Syed Ishrak is the founder of Compute Health Acquisition Corp. (2020, Chairman). Current jobs include Medtronic Trading NL BV (Chairman & Chief Executive Officer), Biofourmis, Inc. (Chairman, 2022), Allurion Technologies, Inc. (Chairman, 2023),. Amgen, Inc. (Independent Director, 2021), Cargill, Inc. (Director, 2021), Insightec Ltd. (Director, 2022), Blood Center of Wisconsin (Director), The Cleveland Clinic Foundation (Director), Save The Children Foundation (Director-Health Leadership Council), Patient Safety Movement Foundation (Director), and Asia Society (Trustee, 2021). Former jobs include Medtronic, Inc. (Chairman & Chief Executive Officer, 2011-2020), Health Care Systems, Inc. (President & Chief Executive Officer), Clinical Systems, Inc. (President & Chief Executive Officer), GE Healthcare, Inc. (President & Chief Executive Officer, 2009-2011), GE Healthcare Clinical Systems (Wisconsin) (President & Chief Executive Officer, 2005-2008), Medtronic Ltd. (Executive Chairman, 2020), Medtronic Plc (Executive Chairman, 2020), Intel Corp. (Independent Director, 2023-2025), GE Aerospace (Senior Vice President), Minnesota Public Radio (Trustee), and Ultrasound, Inc. (General Manager). Education includes undergraduate and doctorate degrees from King's College London. |
| Mary Earley Klotman |
Mary Earley Klotman currently works at Duke University Health System, Inc., as Director, Inventurus Knowledge Solutions, Inc., as Director from 2023, Amgen, Inc., as Independent Director from 2024, Inventurus Knowledge Solutions Ltd., as Independent Director from 2022, National Academy of Medicine (United States), as Member, Duke University, as Dean, and The Rockefeller University, as Trustee. Dr. Klotman also formerly worked at The North Carolina Biotechnology Center, as Director and Association of American Physicians, as President. Dr. Klotman received her doctorate degree from Duke University. |
| Greg C. Garland |
Greg C. Garland currently works at Phillips 66 Co., as Chairman & Chief Executive Officer, Phillips 66 Partners GP LLC, as Chairman & Chief Executive Officer from 2013, The Prium (United States), as Co-Chairman, Amgen, Inc., as Independent Director from 2013, American Petroleum Institute, Inc., as Director from 2022, The National Petroleum Council, as Director, Greater Houston Partnership Inc, as Director, Junior Achievement of Southeast Texas, Inc., as Director, Barbara Bush Houston Literacy Foundation, as Director, Texas A&M University, as Member-Engineering Advisory Council, and The University of Texas M.D. Anderson Cancer Center, as Member-Visitors Board. Mr. Garland also formerly worked at Chevron Phillips Chemical Co. LLC, as President & Chief Executive Officer from 2008 to 2010, Phillips 66 Partners LP, as Chairman & Chief Executive Officer, Phillips 66, as Executive Chairman from 2022 to 2024, American Chemistry Council, Inc., as Director, DCP Midstream LLC (Old), as Director, ConocoPhillips, as Senior VP-Exploration & Americas Production from 2010 to 2012, and Phillips Petroleum Co., as General Manager-Qatar & Middle East Region from 1995 to 2000. Mr. Garland received his undergraduate degree in 1980 from Texas A&M University. |
| Charles M. Holley |
Charles M. Holley currently works at Amgen, Inc., as Independent Director from 2017, Phillips 66, as Independent Director from 2019, Carrier Global Corp., as Independent Director from 2020, Sunrise Group Holdings LLC, as Director, The University of Texas at Austin, as Member-Development Board, Financial Executives International, as Member, McCombs Foundation, Inc., as Member, Texas Society of Certified Public Accountants, as Member, and The Conference Board Council of Financial Executives, as Member. Mr. Holley also formerly worked at The Cancer Challenge, as Director, Walmart, Inc., as Executive Vice President in 2016, Ernst & Young LLP, as Principal, Wal-Mart International, as Chief Financial Officer & Senior Vice President from 1994 to 2002, Tandy Corp., as MD-European Memorex Consumer Product Division, and The First Tee, as Trustee. Mr. Holley received his undergraduate degree from The University of Texas at Austin and Masters Business Admin degree from the University of Houston. |
